Related Experiment Video

Updated: May 17, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Pharmacotherapy of pediatric advanced life support and toxicological emergencies

Lauren M Dandeles1, Kirsten H Ohler

  • 1Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

AACN Advanced Critical Care
|October 26, 2012
PubMed

Insights

Pediatric advanced life support (PALS) guidelines have evolved, highlighting key differences from adult resuscitation. Recognizing age-specific needs in pediatric cardiac arrest management is crucial for effective treatment.

Area of Science:

  • Pediatric Emergency Medicine
  • Cardiology
  • Pharmacology

Background:

  • Pediatric advanced life support (PALS) guidelines have existed for over 20 years.
  • Pharmacological management recommendations for pediatric cardiac arrest have undergone significant changes.
  • Existing guidelines require updates to reflect current knowledge and practices.

Purpose of the Study:

  • To review and summarize current recommendations for the pharmacological management of pediatric cardiac arrest.
  • To highlight key differences between adult and pediatric advanced cardiac life support.
  • To address age-specific considerations in neonatal and pediatric resuscitation.

Main Methods:

  • Review of existing pediatric advanced life support guidelines and relevant literature.
  • Comparative analysis of adult versus pediatric resuscitation protocols.
  • Identification of unique pharmacological needs in pediatric toxicological emergencies.

Main Results:

  • Significant differences exist between adult and pediatric resuscitation, including causes of arrest, monitoring, weight-based dosing, and venous access.
  • Variations in management strategies are noted across neonatal and pediatric age groups.
  • Specific pharmacological agents with unique mechanisms are required for certain pediatric toxicological emergencies.

Conclusions:

  • Effective pediatric cardiac arrest management requires recognition of distinct physiological and clinical differences compared to adults.
  • Age-specific protocols, including weight-based dosing and tailored monitoring, are essential for pediatric resuscitation.
  • Specialized pharmacological approaches are necessary for managing toxicological emergencies in children.

More Related Videos

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...